Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9202 |
High Similarity |
NPD6232 |
Discontinued |
0.9152 |
High Similarity |
NPD7473 |
Discontinued |
0.8929 |
High Similarity |
NPD5844 |
Phase 1 |
0.8889 |
High Similarity |
NPD2801 |
Approved |
0.8667 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8659 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8659 |
High Similarity |
NPD1465 |
Phase 2 |
0.8598 |
High Similarity |
NPD1934 |
Approved |
0.8545 |
High Similarity |
NPD7819 |
Suspended |
0.8531 |
High Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8528 |
High Similarity |
NPD3226 |
Approved |
0.8494 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8443 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.843 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8421 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8421 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8421 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8402 |
Intermediate Similarity |
NPD5494 |
Approved |
0.84 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8393 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8353 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8282 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8282 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8282 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8232 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8232 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8229 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8214 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8204 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8182 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8171 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8171 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8155 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8144 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8144 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8129 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8125 |
Intermediate Similarity |
NPD7472 |
Approved |
0.807 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8063 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.8061 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8059 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8034 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8012 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7978 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7965 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7963 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7953 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD37 |
Approved |
0.7933 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7927 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7919 |
Intermediate Similarity |
NPD919 |
Approved |
0.7907 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7907 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7889 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7845 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7845 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7841 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7829 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7829 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7809 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7805 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7801 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7765 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7764 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7764 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7758 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7737 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6776 |
Approved |
0.773 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7717 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7711 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7702 |
Intermediate Similarity |
NPD943 |
Approved |
0.7702 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7684 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7684 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7683 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7683 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.768 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7651 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7647 |
Intermediate Similarity |
NPD920 |
Approved |
0.7644 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7622 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7614 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7611 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7563 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7563 |
Intermediate Similarity |
NPD7874 |
Approved |
0.756 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7529 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7529 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7526 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7526 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7526 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7515 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7474 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7474 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7473 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7471 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD5405 |
Approved |
0.747 |
Intermediate Similarity |
NPD5404 |
Approved |
0.747 |
Intermediate Similarity |
NPD5406 |
Approved |
0.747 |
Intermediate Similarity |
NPD6100 |
Approved |
0.747 |
Intermediate Similarity |
NPD5408 |
Approved |
0.747 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7469 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7462 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7457 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7389 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7385 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7358 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7356 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD7240 |
Approved |
0.735 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7346 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7333 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7306 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7267 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7258 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7256 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7253 |
Intermediate Similarity |
NPD5242 |
Approved |
0.724 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.724 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.724 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7234 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7231 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7228 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7225 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7222 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7202 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7198 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7195 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7195 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7188 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7173 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7169 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7152 |
Intermediate Similarity |
NPD411 |
Approved |
0.7151 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7128 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7128 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7074 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7074 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7073 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7056 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7056 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7055 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7035
|
Intermediate Similarity |
NPD6674 |
Discontinued |